An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen

Oncogene

Volumn 25, Issue 28, 2006, Pages 3994-4008

  Doane, A S ^a   Danso, M ^a   Lal, P ^a   Donaton, M ^a   Zhang, L ^a   Hudis, C ^a   Gerald, W L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Androgen responsive; Breast cancer; Estrogen receptor negative; Gene expression

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ALCAM GENE; APOD GENE; AR GENE; ARTICLE; BREAST CANCER; CYB5 GENE; FOXA1 GENE; GENE; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NAT1 GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPDEF GENE; TFF3 GENE; TRANSCRIPTION REGULATION; UNINDEXED SEQUENCE; XBP1 GENE;

ANDROGENS; BREAST NEOPLASMS; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; PHENOTYPE; RECEPTORS, ESTROGEN; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 33745603978     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209415     Document Type: Article

References (60)

1. Agoff SN, Swanson PE, Linden H, Hawes SE, Lawton TJ. (2003). Am J Clin Pathol 120: 725-731.
2. Birrell SN, Bentel JM, Hickey TE, Ricciardelli C, Weger MA, Horsfall DJ et al. (1995). J Steroid Biochem Mol Biol 52: 459-467.
3. Buchanan G, Birrell SN, Peters AA, Bianco-Miotto T, Ramsay K, Cops EJ et al. (2005). Cancer Res 65: 8487-8496.
4. Carsol JL, Gingras S, Simard J. (2002). Mol Endocrinol 16: 1696-1710.
5. Cato AC, Nestl A, Mink S. (2002). Sci STKE 2002: RE9.
6. Cunliffe HE, Ringner M, Bilke S, Walker RL, Cheung JM, Chen Y et al. (2003). Cancer Res 63: 7158-7166.
7. de Hoon MJ, Imoto S, Nolan J, Miyano S. (2004). Bioinformatics 20: 1453-1454.
8. DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M et al. (1996). Nat Genet 14: 457-460.
9. Dhanasekaran SM, Dash A, Yu J, Maine IP, Laxman B, Tomlins SA et al. (2005). FASEB J 19: 243-245.
10. Dickson C, Spencer-Dene B, Dillon C, Fantl V. (2000). Breast Cancer Res 2: 191-196.
11. Farmer P, Bonnefoi H, Becette V, Tubiana-Hulin M, Fumoleau P, Larsimont D et al. (2005). Oncogene 24: 4660-4671.
12. Gatalica Z. (1997). Pathol Res Pract 193: 753-758.
13. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP et al. (1999). Science 286: 531-537.
14. Goss PE, Ingle JN, Martino S, Robert NJ, Muss HB, Piccart MJ et al. (2003). N Engl J Med 349: 1793-1802.
15. Greeve MA, Allan RK, Harvey JM, Bentel JM. (2004). J Mol Endocrinol 32: 793-810.
16. Gruber CJ, Tschugguel W, Schneeberger C, Huber JC. (2002). N Engl J Med 346: 340-352.
17. Gruvberger S, Ringner M, Chen Y, Panavally S, Saal LH, Borg A et al. (2001). Cancer Res 61: 5979-5984.
18. Hall RE, Aspinall JO, Horsfall DJ, Birrell SN, Bentel JM, Sutherland RL et al. (1996). Br J Cancer 74: 1175-1180.
19. Hall RE, Birrell SN, Tilley WD, Sutherland RL. (1994). Eur J Cancer 30A: 484-490.
20. Holzbeierlein J, Lal P, LaTulippe E, Smith A, Satagopan J, Zhang L et al. (2004). Am J Pathol 164: 217-227.
21. Howell A, Cuzick J, Baum M, Buzdar A, Dowsett M, Forbes JF et al. (2005). Lancet 365: 60-62.
22. Isola JJ. (1993). J Pathol 170: 31-35.
23. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A et al. (2005). CA Cancer J Clin 55: 10-30.
24. Koziczak M, Hynes NE. (2004). J Biol Chem 279: 50004-50011.
25. Koziczak M, Holbro T, Hynes NE. (2004). Oncogene 23: 3501-3508.
26. Lacroix M, Leclercq G. (2004). Breast Cancer Res Treat 83: 249-289.
27. Laganiere J, Deblois G, Lefebvre C, Bataille AR, Robert F, Giguere V. (2005). Proc Natl Acad Sci USA 102: 11651-11656.
28. Lal P, Tan LK, Chen B. (2005). Am J Clin Pathol 123: 541-546.
29. Lippman M, Bolan G, Huff K. (1976). Cancer Res 36: 4610-4618.
30. Losel RM, Falkenstein E, Feuring M, Schultz A, Tillmann HC, Rossol-Haseroth K et al. (2003). Physiol Rev 83: 965-1016.
31. Matsuo K, Fukutomi T, Hasegawa T, Akashi-Tanaka S, Nanasawa T, Tsuda H. (2002). Breast Cancer 9: 43-49.
32. Mayfield S, Vaughn JP, Kute TE. (2001). Breast Cancer Res Treat 70: 123-129.
33. McKenna NJ, O'Malley BW. (2002). Endocrinology 143: 2461-2465.
34. Mellinghoff IK, Vivanco I, Kwon A, Tran C, Wongvipat J, Sawyers CL. (2004). Cancer Cell 6: 517-527.
35. Miller WR, Telford J, Dixon JM, Shivas AA. (1985). Breast Cancer Res Treat 5: 67-73.
36. Mosmann T. (1983). J Immunol Methods 65: 55-63.
37. Mouridsen H, Gershanovich M, Sun Y, Perez-Carrion R, Boni C, Monnier A et al. (2001). J Clin Oncol 19: 2596-2606.
38. Nagahata T, Onda M, Emi M, Nagai H, Tsumagari K, Fujimoto T et al. (2004). Cancer Sci 95: 218-225.
39. Nantermet PV, Masarachia P, Gentile MA, Pennypacker B, Xu J, Holder D et al. (2005). Endocrinology 146: 564-578.
40. Nelson PS, Clegg N, Arnold H, Ferguson C, Bonham M, White J et al. (2002). Proc Natl Acad Sci USA 99: 11890-11895.
41. Osborne CK, Wakeling A, Nicholson RI. (2004). Br J Cancer 90(Suppl 1): S2-S6.
42. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA et al. (2000). Nature 406: 747-752.
43. Pusztai L, Ayers M, Stec J, Clark E, Hess K, Stivers D et al. (2003). Clin Cancer Res 9: 2406-2415.
44. Rossi S, Graner E, Febbo P, Weinstein L, Bhattacharya N, Onody T et al. (2003). Mol Cancer Res 1: 707-715.
45. Sapp M, Malik A, Hanna W. (2003). Breast J 9: 335-336.
46. Shao D, Lazar MA. (1999). J Clin Invest 103: 1617-1618.
47. Shurbaji MS, Kalbfleisch JH, Thurmond TS. (1996). Hum Pathol 27: 917-921.
48. Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A et al. (2001). N Engl J Med 344: 783-792.
49. Smith IE, Dowsett M. (2003). N Engl J Med 348: 2431-2442.
50. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A et al. (2003). Proc Natl Acad Sci USA 100: 8418-8423.
51. Steketee K, Ziel-van der Made AC, van der Korput HA, Houtsmuller AB, Trapman J. (2004). J Mol Endocrinol 33: 477-491.
52. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. (2005). Proc Natl Acad Sci USA 102: 15545-15550.
53. Tang S, Han H, Bajic VB. (2004). Nucleic Acids Res 32: D533-D536.
54. Tobias JS. (2004). Ann Oncol 15: 1738-1747.
55. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M et al. (2002). Nature 415: 530-536.
56. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F et al. (2005). Lancet 365: 671-679.
57. West M, Blanchette C, Dressman H, Huang E, Ishida S, Spang R et al. (2001). Proc Natl Acad Sci USA 98: 11462-11467.
58. Wilson CA, Dering J. (2004). Breast Cancer Res 6: 192-200.
59. Wong YC, Xie B. (2001). Ital J Anat Embryol 106: 111-125.
60. Yakes FM, Chinratanalab W, Ritter CA, King W, Seelig S, Arteaga CL. (2002). Cancer Res 62: 4132-4141.